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Introduction 
Erectile dysfunction (ED) is a prevalent health problem and impacts considerably on the quality of 
life of middle-aged men (1). Previous studies have reported an association between ED, vascular 
disease (2,3) and cardiovascular risk factors (2-5), with ED being reported to be both a symptom 
and marker of vascular disease progression (6,7).  In Hong Kong there is a high prevalence of 
diabetes and other risk factors, with 22.6% of older males (65-74 years) having diabetes, 37.2% 
dyslipidaemia, and 51.7% hypertension (8).  The Massachusetts Male Aging Study emphasised the 
close relationship between diabetes and ED which was three times more prevalent in diabetic 
subjects than their non-diabetic counterparts (28% vs. 10%) (2).  The high prevalence of diabetes 
and other risk factors may therefore have a significant impact on the prevalence of ED in Hong 
Kong.   
 
Methods  
Patients were diagnosed as having Type 2 diabetes using WHO criteria (9), and underwent 
structured assessments using the EuroDiab Protocol (10). They were seen in a teaching hospital and 
tertiary referral centre, but the government-funded health care system is such that many patients use 
the facility as their only source of subsidised medical care, and represent patients of low and middle 
income socioeconomic status.  
All patients gave written, informed consent.  Assessments for micro- and macrovascular 
disease, including retinopathy, peripheral vascular disease (PVD), and, middle cerebral artery 
(MCA) stenosis using transcranial doppler, blood pressure, and fasting biochemical parameters 
were performed as described previously (11,12).  ED was defined using the 1993 NIH Consensus 
Conference, namely the inability to achieve or maintain an erection sufficient for satisfactory sexual 
activity in the previous year.  Difficulty in developing or maintaining a penile erection sufficient for 
sexual performance ED was reported during a physician-conducted diabetes complication 
screening.   
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Differences in parameters between those with and without ED were examined using the t-
test and χ2-test.  Backwards logistic regression analysis was used to determine independent 
predictors of ED.  The following variables were incorporated into the model in three stages: firstly, 
age, age of diabetes onset and duration; secondly, body mass index, waist circumference, 
haemoglobin A1c, triglycerides, HDL-cholesterol levels, urinary albumin-creatinine ratio, and 
treatments for, and histories of hypertension and diabetes, alcohol consumption and smoking; and 
thirdly, neuropathy, MCA stenosis, PVD, and retinopathy.   
 
Results 
From the 1078 patients aged >30 years recruited, 24.5% reported having ED. Patients reporting ED 
were generally older and the prevalence increased significantly with age increasing from 6.8 to 
35.8% in those aged 30-39 to those >70 years. ED patients had worse glycaemic control, despite 
more having glucose-lowering treatment (p<0.05, Table). Systolic blood pressure was higher in the 
ED patients, although 1.7 times more ED patients were receiving blood pressure-lowering 
pharmacotherapy (p<0.001).  In univariate analysis, increasing glycaemia and hypertension 
increased the risk for having ED with odds ratios (95%CI) of 2.8 (1.2-6.8) and 1.8 (1.3-2.4), 
respectively, but not after adjustment for age and diabetic duration.  ED patients had worse renal 
function, and increased levels of micro- and most macrovascular complications (Table, p<0.05)   
Independent predictors of ED were determined in three stages.  Age [aged 40-49, 50-59, 60-
69, ≥70 years having odds ratio (95%CI) of 2.5 (1.2-5.0), 5.9 (3.0-11.5), 5.3 (2.7-10.4), and 6.8 
(3.3-14.1) compared to those aged 30-39 years, respectively] and duration of diabetes [1.1 (1.02-
1.3)] were found to be independent predictors (χ2=72.3, R2=0.10, all p<0.001).  When 
anthropometric and biochemical parameters were incorporated into the regression analyses, age 
remained an independent predictor of ED, and albumin-creatinine ratio [1.3 (1.04-5.6)] and being 
on treatment for diabetes [4.6 (2.1-10.3)] were also included (χ2=84.2, R2=0.16, all p<0.001).  
Inclusion of concomitant vascular disorders resulted in age, diabetic treatment [3.2 (1.3-7.8)] and 
neuropathy [2.9 (1.7-4.8)] being predictors of ED (χ2=49.9, R2=0.16, all p<0.001). 
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Discussion 
Increasing age was closely related to ED, which is similar to observations in other populations 
(2,13-16).  In Caucasians, risk increased 3.6 times in men aged 50-59 compared to those aged 18-29 
years (2).  The age-related risk in these diabetics was even greater at 5.6 (2.5-12.4) comparing the 
50-59 year age group with those aged 30-39 years, suggesting diabetes may accentuate the effects 
of ageing on ED.  Similarly, diabetic duration, a function of age, was also an independent predictor 
of ED, and probably reflects the cumulative contribution of risk factors to the development of ED.  
Increasing glycaemia increased the risk of ED.  Even moderately high glucose levels affect 
the vasculature (17), and result in the accumulation of advanced glycation end products (18) that 
promote vascular disease and neuropathy, and thus contribute to ED (18).  Penile erection relies on 
neural stimulation of the penile vasculature endothelium and corpus cavernosum lacunae to trigger 
lacunae and smooth muscle relaxation and vasodilatation, which promotes filling and erection (19).  
Risk factors cause vascular damage, diminishing the response at a number of stages, promoting ED 
(17).  Indeed, the albumin-creatinine ratio, a marker of renal function and vascular disease, was an 
independent predictor of ED, and existing vascular disorders were increased with ED.  
Asymptomatic MCA stenosis was commonly identified (~20%) but was not associated with ED, 
suggesting the pathogenesis of this condition may involve a different pattern of risk factors, and 
may contribute to the high prevalence of stroke in Chinese populations (11,12). 
 The observed prevalence of ED of 24.5% is lower than the 63.6% from a smaller Hong 
Kong study (14), but is comparable to a Singaporean study that reported 23.2% had mild ED (13).  
The disparity is probably due to methodological differences in diagnostic criteria, population 
selection and recruitment timing, meaning direct comparisons of studies must be interpreted with 
caution, but do give an estimate of the disease magnitude between the populations.  ED patients 
often do not spontaneously seek help for their condition (6). Therefore, opportunistic screening for 
ED during visits to healthcare workers could help initiate early interventions to treat the ED and 
concomitant vascular risk factors to limit the progression of the associated diabetic complications. 
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In conclusion, Chinese diabetic patients with ED have higher levels of modifiable risk 
factors associated with vascular disease.  Early recognition of ED and risk factor modification 
should reduce vascular disease.  
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Table: Biochemical, anthropometric and complications parameters in 1078 male Type 2 
diabetic Chinese subjects with and without erectile dysfunction 
Parameters Erectile function P values 
 Normal (n=814) Dysfunction (n=264) t-test ANCOVA
Number (total n=1078) 814 264 - - 
Age (years) 53.6 ± 12.5 60.0 ± 10.8 <0.001 - 
Age at diabetes diagnosis (years) 48.4 ± 12.5 52.6 ± 12.0 <0.001 - 
Duration of diabetes (years) 5.1 ± 5.3 7.4 ± 5.7 <0.001 - 
Systolic blood pressure (mm Hg) 133 ± 20 138 ± 23 <0.001 NS 
Diastolic blood pressure (mm Hg) 80 ± 12 79 ± 12 0.088 NS 
Glucose (mmol/L) 8.2 (8.0-8.4) 8.7 (8.3-9.1) 0.022 0.037 
Glycosylated haemoglobin A1c (%) 7.5 (7.4-7.8) 7.8 (7.6-8.0) 0.048 0.084 
Total cholesterol (mmol/L) 5.3 ± 1.2 5.4 ± 1.2 NS NS 
HDL-cholesterol (mmol/L) 1.17 ± 0.32 1.17 ± 0.34 NS NS 
LDL-cholesterol (mmol/L) 3.4 ± 1.0 3.5 ± 0.9 NS NS 
Triglyceride (mmol/L) 1.43 (1.36-1.50) 1.37 (1.27-1.48) NS NS 
Albumin-creatinine ratio (mg/mmol) 2.6 (2.3-2.9) 5.1 (3.9-6.5) <0.001 0.001 
Body mass index (kg/m2) 24.8 ± 3.7 24.1 ± 3.3 0.006 NS 
Waist circumference (cm) 86.9 ± 9.4 86.6 ± 9.0 NS NS 
Peripheral vascular disease  5.6 13.3 <0.001 
Cardiac failure 1.2 3.8 0.012 
Coronary artery bypass graft (CABG) 0 2.8 0.004 
Neuropathy  16.3 45.4 <0.001 
Retinopathy 23.2 40.7 <0.001 
Middle cerebral artery stenosis  20.1 24.3 NS 
Myocardial infarction  1.7 4.6 0.018 
ACR micro/macroalbuminuria  19.6/12.5 26.4/21.2 <0.001 
Prevalence of hypertension (Rx)  46.1 (27.3) 60.2 (42.9) <0.001 (<0.001) 
Prevalence of dyslipidaemia (Rx)  59.3 (5.9) 67.8 (11.3) 0.016 (0.007) 
Drug treatment of diabetes  79.6 96.1 <0.001 
Mean±SD or geometric mean (95% confidence intervals), or prevalence (%) unless other units 
given; NS = Non significant; ANCOVA = analysis of covariance adjusting for age, age of onset of 
diabetes, and duration of diabetes. Dichotomous variable described with χ2 test p value.  Rx= % 
receiving therapy of those with the condition.  (ACR) albumin-to-creatinine ratio 
microalbuminuria= 3.5-30 mg/mmol (20).   
